Qube Research & Technologies (QRT)’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Buy |
1,665,916
+831,067
| +100% | +$7.78M | 0.02% | 736 |
|
|
2025
Q1 | $10.3M | Buy |
834,849
+110,433
| +15% | +$1.36M | 0.01% | 854 |
|
|
2024
Q4 | $9.58M | Buy |
724,416
+41,214
| +6% | +$545K | 0.01% | 857 |
|
|
2024
Q3 | $13.2M | Buy |
683,202
+385,899
| +130% | +$7.43M | 0.02% | 647 |
|
|
2024
Q2 | $6.1M | Buy |
297,303
+203,414
| +217% | +$4.18M | 0.01% | 957 |
|
|
2024
Q1 | $2.23M | Buy |
93,889
+36,528
| +64% | +$869K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $1.24M | Sell |
57,361
-149,033
| -72% | -$3.22M | ﹤0.01% | 1534 |
|
|
2023
Q3 | $3M | Buy |
206,394
+75,636
| +58% | +$1.1M | 0.01% | 942 |
|
|
2023
Q2 | $2.74M | Buy |
130,758
+90,147
| +222% | +$1.89M | 0.01% | 849 |
|
|
2023
Q1 | $858K | Buy |
+40,611
| New | +$858K | ﹤0.01% | 1291 |
|
|
2022
Q2 | – | Sell |
-42,073
| Closed | -$731K | – | 3067 |
|
|
2022
Q1 | $731K | Buy |
+42,073
| New | +$731K | 0.01% | 1318 |
|
|
2020
Q3 | – | Sell |
-20,852
| Closed | -$309K | – | 2073 |
|
|
2020
Q2 | $309K | Buy |
+20,852
| New | +$309K | ﹤0.01% | 1284 |
|